Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas

被引:0
|
作者
Mikami, T [1 ]
Saegusa, M [1 ]
Mitomi, H [1 ]
Yanagisawa, N [1 ]
Ichinoe, M [1 ]
Okayasu, I [1 ]
机构
[1] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 2288555, Japan
关键词
extrahepatic bile duct; carcinoma; E-cadherin; alpha-catenin; beta-catenin; CD44;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas, 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays. Levels of E-cadherin, alpha-catenin, and beta-catenin proteins were lower in carcinomas than in normal mucosa, while CD44 variants 3 and 6 were upregulated. Well-differentiated carcinoma showed higher expression of E-cadherin and alpha-catenin than moderately to poorly differentiated types. Macroscopically, papillary lesions had higher expression of E-cadherin than their nonpapillary counterparts. RT-PCR/SBH for CD44 revealed the CD44 variant form to be more prevalent in carcinoma than in normal mucosa, correlating with the immunohistochemical results, and with more exon variety. The Cox proportional hazards test identified histologic type and E-cadherin expression as prognostic factors. Among the examined molecules, E-cadherin was especially related to papillary mass formation anti a good prognosis.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 49 条
  • [21] CD44 AND E-CADHERIN (EC) EXPRESSION IN TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER (UB-TCC)
    DELROSARIO, AD
    BUI, HX
    WU, AS
    FIGGE, H
    FISHER, HAG
    SHEEHAN, C
    ROSS, JS
    STRATTON, S
    LABORATORY INVESTIGATION, 1994, 70 (01) : A73 - A73
  • [22] Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas
    Tran, TA
    Kallakury, BVS
    Sheehan, CE
    Ross, JS
    HUMAN PATHOLOGY, 1997, 28 (07) : 809 - 814
  • [23] Correlation of CD133, E-cadherin, and β-catenin with metastasis and prognosis in esophageal squamous cell carcinoma
    Zhao, Wenjun
    Qin, Yanzi
    Wu, Xiaofei
    Wu, Shiwu
    Zhao, Yan
    Tao, Yisheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (09): : 9583 - 9592
  • [24] Use of E-cadherin and CD44 for the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings.
    Chhieng, DC
    Yee, H
    Wu, H
    Cangiarella, J
    Symmans, WF
    Waisman, J
    Chiriboga, L
    Ylagan, L
    Cohen, JM
    LABORATORY INVESTIGATION, 1999, 79 (01) : 42A - 42A
  • [25] Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings
    Chhieng, DC
    Yee, H
    Cangiarella, JF
    Symmans, WF
    Cohen, JM
    CANCER CYTOPATHOLOGY, 2000, 90 (05) : 299 - 306
  • [26] Significance of E-cadherin, β-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma
    Cheng, Yong
    Zhou, Ying
    Jiang, Wenjing
    Yang, Xia
    Zhu, Jing
    Feng, Dingqing
    Wei, Ying
    Li, Min
    Yao, Fengqiu
    Hu, Weiping
    Xiao, Weihua
    Ling, Bin
    HUMAN PATHOLOGY, 2012, 43 (08) : 1213 - 1220
  • [27] Immunophenotypic and prognostic analysis of E-cadherin and β-catenin expression during breast carcinogenesis and tumour progression:: a comparative study with CD44
    Bànkfalvi, A
    Terpe, HJ
    Breukelmann, D
    Bier, B
    Rempe, D
    Pschadka, G
    Krech, R
    Lellè, RJ
    Boecker, W
    HISTOPATHOLOGY, 1999, 34 (01) : 25 - 34
  • [28] Expression of miR-373 and its predicted target genes E-cadherin and CD44 in patients with laryngeal squamous cell carcinoma
    Timirci-Kahraman, Ozlem
    Verim, Aysegul
    Farooqi, Ammad Ahmad
    Turan, Saime
    Ozkan, Nazli Ezgi
    Yaylim, Ilhan
    CELLULAR AND MOLECULAR BIOLOGY, 2017, 63 (12) : 29 - 33
  • [29] Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas (NSCLCs).
    Tran, TA
    Kallakury, BVS
    Ross, JS
    LABORATORY INVESTIGATION, 1996, 74 (01) : 957 - 957
  • [30] Differential expression of Oct-4, CD44, and E-cadherin in eutopic and ectopic endometrium in ovarian endometriomas and their correlations with clinicopathological variables
    Usta, Ceyda Sancakli
    Turan, Gulay
    Bulbul, Cagla Bahar
    Usta, Akin
    Adali, Ertan
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2020, 18 (01)